Cure8 research brief
IBD cases are increasing in Sub-Saharan Africa but care and research remain limited and driven by high-income country priorities. Region-specific research and policy changes could improve diagnosis, treatment access, and equity for people with IBD in SSA.
Patients and caregivers in Sub-Saharan Africa; clinicians and health systems in SSA; global IBD researchers; funders and policymakers focused on health equity.
The article synthesizes challenges specific to SSA — for example, limited local research, treatment guidelines designed for high-income settings, and gaps in accessibility and equity of IBD care. It outlines priorities and proposes a contextually relevant research and practice agenda, building on existing initiatives.
This is a viewpoint/agenda article based on an emerging body of regional research and expert synthesis (abstract-level content). It proposes priorities rather than reporting primary clinical trial findings.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This registry study shows many people with IBD in Kazakhstan had clinically active disease at enrollment and identifies factors linked with active UC and CD. It highlights potential gaps in disease control and...
Clinical trials expand treatment options and are how new IBD therapies are tested and approved. Low enrollment can delay access to future treatments for Crohn’s and ulcerative colitis.
This large, population-level analysis summarizes long-term global trends in IBD burden and shows rising incidence and persistent geographic and socio-demographic inequalities. Patients and clinicians may see why...
